AMANTADINE Drug Patent Profile
✉ Email this page to a colleague
When do Amantadine patents expire, and what generic alternatives are available?
Amantadine is a drug marketed by Zydus, Actavis Elizabeth, Alembic, Bionpharma, Chartwell Molecular, Heritage Pharma, Humanwell Puracap, Invagen Pharms, Onesource Specialty, Rising, Rubicon Research, Sandoz, Strides Pharma, Upsher Smith Labs, Watson Labs, Watson Labs Inc, Zydus Pharms, Adaptis, Aurobindo Pharma Usa, Chartwell Rx, G And W Labs Inc, Ph Health, Pharm Assoc, Pharmobedient, Pom Pharma, Teva Pharms, Jubilant Generics, and Zhejiang Jutai Pharm. and is included in thirty-six NDAs.
The generic ingredient in AMANTADINE is amantadine hydrochloride. There are seven drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the amantadine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amantadine
A generic version of AMANTADINE was approved as amantadine hydrochloride by UPSHER SMITH LABS on August 5th, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AMANTADINE?
- What are the global sales for AMANTADINE?
- What is Average Wholesale Price for AMANTADINE?
Summary for AMANTADINE
| US Patents: | 0 |
| Applicants: | 28 |
| NDAs: | 36 |
| Drug Prices: | Drug price information for AMANTADINE |
| DailyMed Link: | AMANTADINE at DailyMed |
US Patents and Regulatory Information for AMANTADINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pom Pharma | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | TABLET;ORAL | 210215-001 | Mar 10, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Adaptis | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | TABLET;ORAL | 212407-001 | May 27, 2022 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Strides Pharma | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | TABLET;ORAL | 209035-001 | Jun 9, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Alembic | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | TABLET;ORAL | 214284-001 | Oct 15, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
